The Effect of DPP4 Inhibitor on Glycemic Variability in Patients with Type 2 Diabetes treated with twice-daily Premixed Human Insulin*

OBJECTIVE: To evaluate the effect of adding DPP4 inhibitor (DPP4-i) on glycemic variability (GV) in patients with type 2 diabetes mellitus (T2DM) treated with premixed human insulin (MHI). METHODOLOGY: We conducted a prospective study in patients with T2DM on twice-daily MHI with or without metformi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Florence Hui Sieng, Tong, Chin Voon, Tiong, Xun Ting, Lau, Bik Kui, Kuan, Yueh Chien, Loh, Huai Heng, Pillai, Saravanan A/L Vengadesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the ASEAN Federation of Endocrine Societies 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666489/
https://www.ncbi.nlm.nih.gov/pubmed/34966201
http://dx.doi.org/10.15605/jafes.036.02.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666489/
https://www.ncbi.nlm.nih.gov/pubmed/34966201
http://dx.doi.org/10.15605/jafes.036.02.11

Ejemplares similares